FindTrial
Sign In

Dose Response Trial of Pergolide for Cocaine Dependence - 1

Dose Response Trial of Pergolide for Cocaine Dependence

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00000248
Enrollment
0
Registered
1999-09-21
Start date
1996-02-29
Completion date
Unknown
Last updated
2018-05-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cocaine-Related Disorders

Brief summary

The purpose of this study is to evaluate the efficacy and safety of pergolide for treatment of cocaine dependence.

Interventions

DRUGPergolide

Sponsors

National Institute on Drug Abuse (NIDA)
CollaboratorNIH
Medical University of South Carolina
Lead SponsorOTHER

Study design

Primary purpose
TREATMENT

Eligibility

Sex/Gender
ALL
Age
21 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

Please contact site for information.

Design outcomes

Primary

MeasureTime frame
Cocaine withdrawal—
Compliance—
Effectiveness of medication for global improvements—
Side effects—
Drug use—
Retention—

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026